Table 2. Univariate analysis of the factors affecting the survival of the Uyghur HCC patients.
| Variables | No. of cases | Survival rate (%) |
χ2 | P | |||
|---|---|---|---|---|---|---|---|
| 0.5-year | 1-year | 3-year | 5-year | ||||
| Age (years) | 8.757 | 0.003 | |||||
| <60 | 131 | 79.4 | 42.9 | 19.8 | 8.0 | ||
| ≥60 | 170 | 71.2 | 30.1 | 6.2 | 1.8 | ||
| Area of residence | 3.888 | 0.049 | |||||
| Urban | 171 | 79.5 | 40.3 | 13.9 | 4.3 | ||
| Rural | 130 | 60.6 | 24.8 | 6.3 | 2.7 | ||
| Diabetes mellitus | 5.007 | 0.025 | |||||
| Present | 222 | 72.5 | 32.1 | 10.4 | 3.7 | ||
| Absent | 79 | 81.0 | 44.3 | 26.8 | 7.0 | ||
| Tumour stage | 47.158 | 0.000 | |||||
| I/II | 123 | 88.6 | 57.9 | 27.9 | 10.8 | ||
| III/IV | 178 | 64.6 | 20.2 | 2.0 | 0.0 | ||
| Liver cirrhosis | 4.338 | 0.037 | |||||
| Present | 137 | 78.8 | 44.5 | 15.2 | 5.5 | ||
| Absent | 164 | 71.3 | 28.0 | 9.6 | 2.9 | ||
| PVTT | 35.763 | 0.000 | |||||
| Present | 140 | 88.2 | 51.6 | 20.3 | 7.0 | ||
| Absent | 161 | 59.3 | 17.5 | 3.5 | 0.0 | ||
| Child-Pugh class | 31.564 | 0.000 | |||||
| A | 130 | 83.1 | 47.4 | 18.9 | 7.4 | ||
| B | 116 | 74.1 | 34.4 | 9.8 | 3.7 | ||
| C | 55 | 56.4 | 10.9 | 2.1 | 0.0 | ||
| AFP (μg·L−1) | 7.289 | 0.026 | |||||
| ≤20 | 118 | 72.9 | 38.2 | 17.9 | 3.6 | ||
| 20-200 | 67 | 77.1 | 44.8 | 16.6 | 3.6 | ||
| >200 | 125 | 75.2 | 28.4 | 5.3 | 2.7 | ||
| Curative surgery | 26.015 | 0.000 | |||||
| Yes | 275 | 72.7 | 31.7 | 7.9 | 3.5 | ||
| No | 26 | 96.0 | 78.6 | 65.2 | 19.8 | ||
| TACE | 29.990 | 0.000 | |||||
| Yes | 97 | 86.6 | 60.0 | 23.3 | 7.3 | ||
| No | 204 | 69.1 | 24.1 | 7.3 | 2.6 | ||
| TACE and radiotherapy or RFA | 20.645 | 0.000 | |||||
| Yes | 124 | 84.7 | 50.8 | 18.3 | 6.3 | ||
| No | 177 | 67.7 | 25.0 | 7.9 | 3.0 | ||
HCC, hepatocellular carcinoma; PVTT, portal vein tumour thrombus; AFP, alpha-fetoprotein; TACE, transcatheter hepatic arterial chemoembolisation; RFA, radiofrequency ablation.